Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial K(ATP) channel

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 10, 1999, Pages 1821-1831

  Asemu, Girma ^a   Papoušek, František ^a   Ošťádal, Bohuslav ^a   Kolář, František ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Arrhythmias; Chronic hypoxia; Ischemia; K(ATP) channels; Protection

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT;

ADAPTATION; ALTITUDE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HYPOXIA; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0344172553     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1013     Document Type: Article

References (50)

1. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 26:1992;1054-1062.
2. ATPchannel activation in a rabbit model of chronic myocardial hypoxia. J Mol Cell Cardiol. 29:1997a;845-848.
3. ATPchannel. Circulation. 95:1997b;1278-1285.
4. Baker JE, Holman P, Kalyanaraman B, Pritchard KA. Adaptation of hearts to chronic hypoxia increases tolerance to subsequent ischemia by increased nitric oxide production. In Hudetz AG and Bruley DF (eds). Oxygen Transport to Tissue XX. New York and London: Plenum Press. 1998;203-217.
5. ATPchannels. Circulation. 99:1999;1249-1254.
6. +channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias. Eur J Pharmacol. 326:1997;147-156.
7. Cameron JS, Baghdady R. Role of ATP sensitive potassium channels in long term adaptation to metabolic stress. Cardiovasc Res. 28:1994;788-796.
8. Downey JM, Cohen MV. Signal transduction in ischemic preconditioning. Adv Exp Med Biol. 430:1997;39-55.
9. Garlid KD. Cation transport in mitochondria - the potassium cycle. Biochim Biophys Acta. 1275:1996;123-126.
10. +channels. Possible mechanism of cardioprotection. Circ Res. 81:1997;1072-1082.
11. ATPchannel as a receptor for potassium channel openers. J Biol Chem. 271:1996;8796-8799.
12. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol. 75:1997;309-315.
13. ATPopener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 26:1995;145-152.
14. ATPchannel opener. J Mol Cell Cardiol. 30:1998;1369-1379.
15. Hearse DJ. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res. 30:1995;1-17.
16. Heath D, Williams DR. Man at High Altitude. Edinburgh: Churchill Livingstone. 1981.
17. Hide EJ, Thiemermann C. Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate. Cardiovasc Res. 31:1996;941-946.
18. +channels modulate cardiac mitochondrial function. Am J Physiol. 275:1998;H1567-H1576.
19. +channel in the mitochondrial inner membrane. Nature. 352:1991;244-247.
20. ATPchannel by gliburide and 5-hydroxydecanoate. J Biol Chem. 273:1998;13578-13582.
21. +loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res. 66:1990;478-485.
22. Kolář F. Cardioprotective effects of chronic hypoxia: Relation to preconditioning. In Wainwright CL and Parratt JR (eds). Myocardial Preconditioning. Berlin: Springer Verlag. 1996;261-275.
23. Kolář F, Parratt JR. Antiarrhythmic effect of ischemic preconditioning in hearts of spontaneously hypertensive rats. Exp Clin Cardiol. 2:1997;124-127.
24. Kopecky M, Daum S. Tissue adaptation to anoxia in rat myocardium (in Czech). Čs Fysiol. 7:1958;518-521.
25. ATPchannel. Am J Physiol. 40:1996;H1769-H1777.
26. Liu Y, Gao WD, O'Rourke B, Marban E. Cell-type specificity of preconditioning in an in vitro model. Basic Res Cardiol. 91:1996;450-457.
27. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection? Circulation. 97:1998;2463-2469.
28. McGrath JJ, Bullard RW. Altered myocardial performance in response to anoxia after high-altitude exposure. J Appl Physiol. 25:1968;761-764.
29. McGrath JJ, Procházka J, Pelouch V, Ošťádal B. Physiological responses of rats to intermittent high altitude stress. Effect of age. J Appl Physiol. 34:1973;289-293.
30. Meerson FZ, Gomzakov OA, Shimkovich MV. Adaptation to high altitude hypoxia as a factor preventing development of myocardial ischemic necrosis. Am J Cardiol. 31:1973;30-34.
31. Meerson FZ, Malyshev IY, Zamotrinsky AV. Differences in adaptive stabilization of structures in response to stress and hypoxia relate with the accumulation of hsp70 isoforms. Mol Cell Biochem. 111:1992;87-95.
32. Meerson FZ, Ustinova EE, Orlova EH. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol. 10:1987;783-789.
33. Ming Z, Nordin C, Aronson RS. Role of L-type Ca channel window current in generating current-induced early afterdepolarizations. J Cardiovasc ElectroÍphysiol. 5:1994;323-334.
34. Moret PR. Hypoxia and the heart. In Bourne GH (ed). Hearts and Heart-like Organs. Edinburgh: Churchill Livingstone. 1980;333-387.
35. Novel-Chaté V, Mateo P, Saks VA, Hoerter JA, Rossi A. Chronic exposure of rats to hypoxic environment alters the mechanism of energy transfer in myocardium. J Mol Cell Cardiol. 30:1998;1295-1303.
36. Ošťádal B, Kolář F, Pelouch V, Procházka J, Widimsky J. Intermittent high altitude and the cardiopulmonary system. In Nagano M, Takeda N, Dhalla NS (eds). The Adapted Heart. New York: Raven Press. 1994;173-192.
37. Parratt JR. Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol. 27:1995;991-1000.
38. Pell TJ, Baxter GF, Yellon DM, Drew GM. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol. 275:1998;H1542-H1547.
39. Pell TJ, Yellon DM, Goodwin RW, Baxter GF. Myocardial ischemic tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc Drugs Ther. 11:1997;679-686.
40. Piacentini L, Wainwright CL, Parratt JR. The antiarrhythmic effect of ischaemic preconditioning in isolated rat hearts involves a pertussis toxin sensitive mechanism. Cardiovasc Res. 27:1993;674-680.
41. Poupa O, Krofta K, Procházka J, Turek Z. Acclimatization to simulated high altitude and acute cardiac necrosis. Fed Proc. 25:1966;1243-1246.
42. Roden DM. Early after-depolarizations and torsade de pointes: Implications for the control of cardiac arrhythmias by prolonging repolarization. Eur Heart J. 14 (suppl H):1993;56-61.
43. Sahai A, Mei C, Zavosh A, Tannen RL. Chronic hypoxia induces LLC-PK1 cell proliferation and dedifferentiation by the activation of protein kinase C. Am J Physiol. 272:1997;F809-F815.
44. +channels by protein kinase C. Circ Res. 83:1998;110-114.
45. ATPchannel antagonist, 5-hydroxyÍdecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 29:1997;1055-1060.
46. Tajima M, Katayose D, Bessho M, Isoyama S. Acute ischaemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. Cardiovasc Res. 28:1994;312-319.
47. Tosaki A, Szerdahelyi P, Engelman RM, Das DK. Potassium channel openers and blockers: Do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther. 267:1993;1355-1362.
48. Turek Z, Kubát K, Ringnalda BEM, Kreuzer F. Experimental myocardial infarction in rats acclimated to simulated high altitude. Basic Res Cardiol. 75:1980;544-553.
49. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DWG, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B. The Lambeth conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res. 22:1988;447-455.
50. Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS. Ischemic preconditioning: present position and future directions. Cardiovasc Res. 37:1998;21-33.